Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10035804 Spirodiamine derivatives as aldosterone synthase inhibitors

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
April 5, 2017
Date of Patent
July 31, 2018
Patent Application Number
15479701
Patent Citations Received
‌
US Patent 11639346 Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS
0
‌
US Patent 11274093 Fused bicyclic benzoheteroaromatic compounds and methods of use thereof
0
‌
US Patent 11279689 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1 yl)prop-2-en-1-one derivatives and similar compounds as KRAS G12C modulators for treating cancer
‌
US Patent 12134620 Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer
0
‌
US Patent 11358959 Benzothiophene and benzothiazole compounds and methods of use thereof
‌
US Patent 11377441 Covalent inhibitors of KRAS
‌
US Patent 11878985 Substituted quinazolines as inhibitors of KRAS G12C
0
‌
US Patent 11059819 Fused hetero-hetero bicyclic compounds and methods of use thereof
0
Patent Inventor Names
Yongfu Liu
0
Dongbo Li
0
Alexander Mayweg
0
Benoit Hornsperger
0
Bernd Kuhn
0
Hans Peter Maerki
0
Jianhua Yu
0
Johannes Aebi
0
Jun Wu
0
Junli Chen
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10035804
Patent Primary Examiner
‌
Alexander R Pagano

Find more entities like US Patent 10035804 Spirodiamine derivatives as aldosterone synthase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo